Melatonin Benefits: Complete Research Review and Evidence Analysis

"What are the benefits of melatonin?"

Simple enough question.

But the answer is more nuanced than most supplements would have you believe.

Yes, melatonin helps with sleep—but how much improvement can you actually expect? The studies show 7-12 minutes faster sleep onset on average.^[1] Meaningful for some people, modest for others. And what about all the other claimed benefits: antioxidant protection, immune support, anti-aging effects, cognitive enhancement, migraine prevention? Are these legitimate, exaggerated, or completely unfounded?

This guide examines melatonin's benefits through the lens of actual research: what the clinical trials show, how significant the effects are, which benefits have strong evidence versus weak evidence, and most importantly, what you can realistically expect if you use melatonin.

We're not here to sell you on miraculous transformations. We're here to give you the scientific truth about what melatonin does, doesn't do, and might do based on current evidence.

Understanding real benefits helps you make informed decisions about whether melatonin is worth trying for YOUR specific goals.

---

Table of Contents

1. How to Interpret Melatonin Research
2. Sleep Benefits: What the Data Actually Shows
3. Circadian Rhythm Regulation Benefits
4. Antioxidant and Cellular Protection
5. Immune System Support
6. Cognitive Protection and Brain Health
7. Migraine and Headache Prevention
8. Eye Health and Vision Protection
9. Cardiovascular Benefits
10. What Melatonin Doesn't Do (Debunking Hype)
11. Melatonin Benefits Questions Answered

---

1. How to Interpret Melatonin Research

Before diving into specific benefits, you need to understand how to read supplement research critically.

The Quality Hierarchy

Tier 1: Systematic Reviews and Meta-Analyses

• Analyze multiple randomized controlled trials
• Statistical pooling of results
• Highest evidence quality
• Example: "Meta-analysis of 19 trials on melatonin for insomnia"

Tier 2: Randomized Controlled Trials (RCTs)

• Participants randomly assigned to melatonin or placebo
• Double-blind (neither participants nor researchers know who gets what)
• Good evidence, but single study
• Example: "RCT of 100 participants, melatonin vs placebo for 4 weeks"

Tier 3: Observational Studies

• Compare people who use melatonin to those who don't
• No random assignment
• Cannot prove causation
• Example: "Survey of 1,000 shift workers using melatonin"

Tier 4: Animal and Cell Studies

• Interesting mechanisms but uncertain human relevance
• Often use doses impossibly high for humans
• Hypothesis-generating, not proof
• Example: "Melatonin protects rat neurons from oxidative stress"

Tier 5: Case Reports and Anecdotes

• Individual stories
• Cannot generalize
• Useful for rare side effects, not for proving benefits

Statistical vs Clinical Significance

Statistical significance: Result unlikely to be due to chance (p < 0.05)

Clinical significance: Result actually matters to your health/quality of life

Example: Sleep onset time

• Melatonin reduces sleep onset by 7 minutes (statistically significant)
• Is 7 minutes clinically meaningful? Depends on your situation.
• If you're taking 90 minutes to fall asleep → 7 minutes is minimal
• If you're taking 20 minutes to fall asleep → 7 minutes is 35% improvement

The disconnect: Many "statistically significant" benefits are clinically trivial. Always ask: "How big is the effect?"

Effect Sizes Matter

Small effect: Cohen's d = 0.2-0.5 (detectable but minor) Medium effect: Cohen's d = 0.5-0.8 (noticeable improvement) Large effect: Cohen's d > 0.8 (substantial benefit)

Melatonin's typical effect sizes:

• Sleep onset: d = 0.34 (small-moderate)
• Jet lag: d = 0.76 (moderate-large)
• DSPS: d = 0.82 (large)
• General insomnia: d = 0.19 (very small)

Study Duration Limitations

Most melatonin trials: 2-12 weeks

Long-term data (6+ months): Limited

What this means: Short-term benefits well-established, long-term effects less certain

Critical question: Does effectiveness persist with chronic use? Research suggests yes for appropriate indications, but data beyond 1-2 years is sparse.

---

2. Sleep Benefits: What the Data Actually Shows

Sleep is melatonin's primary evidence-based benefit—but the effects are more modest than marketing suggests.

Sleep Onset (Falling Asleep)

Meta-analysis findings (19 studies, 1,683 participants):

• Average improvement: 7.06 minutes faster sleep onset
• Range: 4-15 minutes depending on study
• Effect size: Small to moderate (d = 0.34)

Who benefits most:

• Older adults (65+): 12-20 minute improvement^[3]
• DSPS patients: 15-34 minute improvement
• Jet lag: 15-25 minute improvement
• Shift workers: 10-18 minute improvement

Who benefits least:

• Young healthy adults with no sleep issues: <5 minutes
• Primary insomnia (anxiety-driven): 3-8 minutes
• Sleep maintenance issues: Minimal benefit

Clinical insight: Melatonin is most effective when there's genuine circadian disruption or age-related deficiency, NOT for overriding poor sleep habits.

Total Sleep Time

Average improvement: 8.25 minutes additional sleep per night^[2]

Range across studies: -5 minutes to +25 minutes

Interpretation: Modest increase. Not transformative, but adds up over weeks.

Important caveat: Total sleep time improvement mainly from falling asleep faster, NOT sleeping later. Melatonin doesn't extend sleep duration significantly.

Sleep Quality (Subjective)

Findings: 55-60% of users report "better sleep quality"

Challenges:

• Subjective measure (hard to quantify)
• Placebo response strong (40-45% report improvement on placebo)
• Real benefit: ~15-20% above placebo

Objective measures (polysomnography):

• Slight increase in REM sleep percentage (3-5%)
• Minimal change in slow-wave sleep
• Preserves natural sleep architecture (unlike sleeping pills)

Key advantage: Doesn't distort sleep stages like benzodiazepines or Z-drugs do.

Sleep Efficiency

Sleep efficiency = (Time asleep / Time in bed) × 100

Typical improvement: 2-5 percentage points

Example:

• Baseline: 82% efficiency (6.5 hours asleep in 8-hour window)
• With melatonin: 86% efficiency (6.9 hours asleep)
• Real benefit: 24 extra minutes of sleep

Clinically meaningful threshold: Efficiency <85% is problematic. Melatonin can help push marginal cases into healthy range.

Comparison to Sleeping Pills

Effectiveness comparison:

Sleeping Pills (benzodiazepines, Z-drugs):

• Sleep onset: 20-30 minutes faster
• Total sleep: +25-35 minutes
• Dependency: High risk
• Next-day function: Impaired

Melatonin:

• Sleep onset: 7-12 minutes faster
• Total sleep: +8-13 minutes
• Dependency: None
• Next-day function: Minimal impairment

The tradeoff: Sleeping pills are "stronger" but come with significant risks. Melatonin is gentler but safer for long-term use.

Complete sleep improvement guide →

---

3. Circadian Rhythm Regulation Benefits

This is where melatonin truly excels—circadian timing correction shows the largest, most consistent benefits.

Jet Lag Prevention and Recovery

Evidence quality: STRONG (multiple meta-analyses)

Effectiveness:

• Reduces jet lag severity by 50-70%
• Accelerates adjustment by 2-3 days
• Effect size: 0.76 (moderate-large)

Optimal protocol:

• Eastward travel: 0.5-5mg at target bedtime
• Westward travel: Less critical, but can help
• Start 2-3 days before departure if possible

Number Needed to Treat (NNT): 2.3 (for every 2.3 people who use melatonin, 1 avoids significant jet lag)

Why it works so well: Jet lag is pure circadian misalignment—exactly what melatonin addresses.

Complete jet lag protocol →

Delayed Sleep Phase Syndrome (DSPS)

Evidence quality: STRONG

Effectiveness:

• Phase advance of 1-2 hours achievable in 70-80% of patients
• Combined with morning light: even better results
• Effect size: 0.82 (large)

Typical results:

• Sleep onset moves 60-90 minutes earlier
• Wake time moves 60-90 minutes earlier
• Takes 2-4 weeks of consistent use

Important: Requires afternoon/early evening timing (4-6 hours before current sleep onset), NOT bedtime dosing.

Shift Work Sleep Disorder

Evidence quality: MODERATE

Effectiveness:

• Daytime sleep quality improves 30-40%
• Total sleep time increases 25-45 minutes
• Adaptation to night schedule accelerated

Challenges:

• Full circadian reversal difficult to achieve
• Weekend reversion to normal schedule undoes progress
• Rotating shifts hardest (constant change prevents adaptation)

Best results: Permanent night shift workers who maintain nocturnal schedule 7 days/week

Shift work protocol →

Seasonal Affective Disorder (SAD)

Evidence quality: WEAK-MODERATE (limited studies)

Hypothesis: Circadian disruption contributes to winter depression

Some evidence for:

• Morning light + evening melatonin combination
• May help regulate disrupted winter rhythms
• NOT a standalone SAD treatment

Better established: Bright light therapy alone

---

4. Antioxidant and Cellular Protection

Melatonin is a powerful antioxidant in laboratory settings—but translating this to human health benefits is complex.

The Antioxidant Evidence

In vitro (cell studies):

• Melatonin scavenges free radicals directly
• More potent than vitamin C or E in some assays
• Protects mitochondria from oxidative damage

Animal studies:

• Protects against radiation-induced damage
• Reduces oxidative stress in various organs
• Extends lifespan in some species

Human evidence: LIMITED

The challenge: Achieving blood levels in humans comparable to effective laboratory concentrations requires massive doses (50-100mg+)—far above typical sleep doses (0.3-5mg).

Potential Clinical Applications

Strongest evidence:

• Perioperative oxidative stress reduction (surgery patients)
• Some neurodegenerative diseases (adjunct therapy)

Moderate evidence:

• Age-related macular degeneration (eye protection)
• Cardiovascular oxidative damage

Weak evidence:

• Cancer prevention
• General "anti-aging"

Critical assessment: While melatonin IS a powerful antioxidant biochemically, evidence for meaningful antioxidant-related health benefits at typical doses (0.3-5mg) is limited.

Exception: Sleep-dose melatonin may still provide some antioxidant benefit overnight when natural production would normally peak.

---

5. Immune System Support

Evidence quality: MODERATE (mostly animal/observational)

The Immune-Melatonin Connection

Mechanisms:

• Melatonin receptors on immune cells (T cells, B cells, macrophages)
• Regulates cytokine production
• Modulates inflammation
• Affects immune cell proliferation

Circadian immunity: Immune function follows circadian rhythm—melatonin coordinates timing of immune responses.

Human Evidence

Stronger evidence:

• Improved immune response to vaccines (some studies)
• Reduced severity of respiratory infections in elderly (limited data)
• Inflammation reduction in specific conditions

Weaker evidence:

• General immune "boosting" (poorly defined term)
• Cancer immune surveillance
• Autoimmune disease management

COVID-19 adjunct therapy:

• Multiple trials investigated melatonin as COVID-19 treatment
• Results mixed: some showed benefit, others did not
• Mechanism: Anti-inflammatory + antioxidant effects
• Conclusion: Possible adjunct benefit, NOT standalone treatment

Clinical reality: Most immune benefits are theoretical or based on animal studies. Human evidence is preliminary.

---

6. Cognitive Protection and Brain Health

Evidence quality: WEAK-MODERATE (mostly preventive, long-term outcomes)

Neuroprotection Evidence

Animal studies show:

• Protection against Alzheimer's-like pathology
• Reduced beta-amyloid accumulation
• Improved mitochondrial function in neurons
• Reduced neuroinflammation

Human studies show:

• Possible reduced Alzheimer's risk with long-term melatonin use (observational)
• Improved sleep quality in Alzheimer's patients
• Modest cognitive benefits in mild cognitive impairment (small studies)

The mechanism:

• Antioxidant effects in brain
• Improved sleep quality (sleep crucial for brain health)
• Anti-inflammatory effects

Current Cognitive Function

Short-term cognitive benefits: MINIMAL

Melatonin doesn't:

• Improve memory acutely
• Enhance focus or attention
• Boost processing speed

What it might do:

• Prevent age-related decline (long-term)
• Protect against neurodegenerative disease development
• Improve cognition indirectly via better sleep

Clinical assessment: Preventive benefits possible but not proven. NOT a cognitive enhancer for healthy individuals.

---

7. Migraine and Headache Prevention

Evidence quality: MODERATE

Research Findings

Effectiveness:

• 3mg nightly: Reduced migraine frequency by 50% in small studies
• Number of migraine days reduced by 2.7 days/month
• Migraine intensity reduced in some patients

Comparison to standard preventives:

• Similar effectiveness to some prescription preventives
• Better tolerability than many medications
• Fewer side effects

Mechanism (hypothesized):

• Melatonin receptors involved in pain modulation
• Anti-inflammatory effects
• Improved sleep quality (poor sleep triggers migraines)
• Membrane stabilization

Clinical Use

Typical protocol:

• 3mg melatonin nightly at bedtime
• Takes 8-12 weeks to show full effect
• Works better for migraine prevention than acute treatment

Who benefits:

• Chronic migraine patients (>15 days/month)
• People with sleep-related migraine triggers
• Patients who can't tolerate standard preventives

Important: NOT for acute migraine treatment—used for prevention only.

Evidence strength: Enough to warrant trying in migraine patients, but not first-line treatment yet.

---

8. Eye Health and Vision Protection

Evidence quality: WEAK-MODERATE

Mechanisms

Melatonin in the eye:

• Retina produces melatonin locally
• Protects photoreceptors from oxidative damage
• Regulates intraocular pressure
• Involved in retinal circadian rhythms

Potential Benefits

Age-related macular degeneration (AMD):

• Animal studies: protective effects
• Human studies: very limited
• Hypothesis: Antioxidant protection of retinal cells
• Current status: Insufficient evidence for recommendation

Glaucoma:

• Melatonin reduces intraocular pressure in some studies
• Effects modest and inconsistent
• NOT a replacement for standard glaucoma treatment

Retinopathy:

• Some protective effects in diabetic retinopathy (animal models)
• Human evidence lacking

Clinical reality: Promising laboratory research, but clinical benefits in humans not well-established.

---

9. Cardiovascular Benefits

Evidence quality: WEAK-MODERATE

Blood Pressure Effects

Findings:

• Melatonin reduces blood pressure by 3-5 mmHg (both systolic and diastolic)
• Effect more pronounced in hypertensive individuals
• Nighttime dosing especially effective

Mechanism:

• Direct vasodilation
• Reduced sympathetic nervous system activity
• Antioxidant effects on blood vessels

Clinical significance:

• Modest reduction, not replacement for BP medication
• May allow dose reduction of antihypertensives (under medical supervision)

Heart Health Markers

Some evidence for:

• Reduced LDL oxidation
• Improved endothelial function
• Reduced inflammation markers (CRP)

Observational data:

• Some studies link melatonin use with reduced cardiovascular events
• Confounding factors make interpretation difficult

Current consensus: Possible cardiovascular benefits, but not proven. NOT a cardiovascular treatment.

---

10. What Melatonin Doesn't Do (Debunking Hype)

Separating evidence-based benefits from marketing claims.

"Melatonin is a miracle anti-aging supplement"

Claim: Melatonin reverses aging, extends lifespan dramatically

Reality:

• Animal studies show lifespan extension in some species
• Human aging studies non-existent
• Sleep improvement may indirectly support healthy aging
• No evidence for dramatic anti-aging effects in humans

Verdict: OVERHYPED

"Melatonin cures insomnia"

Claim: Melatonin solves all sleep problems

Reality:

• Modest sleep improvement (7-12 minutes faster onset)
• Most effective for circadian issues, NOT primary insomnia
• CBT-I more effective for chronic insomnia
• Doesn't address anxiety, sleep apnea, or other underlying causes

Verdict: OVERSTATED

"Melatonin boosts immune system"

Claim: Melatonin dramatically strengthens immunity

Reality:

• Has immunomodulatory effects (receptors on immune cells)
• Human evidence for immune "boosting" weak
• May help in specific contexts (vaccines, elderly)
• Not a substitute for healthy lifestyle immune support

Verdict: THEORETICAL, NOT PROVEN

"Melatonin prevents cancer"

Claim: Melatonin is cancer-preventive or anti-cancer

Reality:

• Cell and animal studies show anti-cancer properties
• Epidemiological data mixed and inconsistent
• Some trials as adjunct to cancer treatment (results varied)
• NO evidence as standalone cancer prevention

Verdict: PREMATURE

"Melatonin is a powerful nootropic"

Claim: Melatonin enhances memory, focus, cognition

Reality:

• No evidence for acute cognitive enhancement
• May protect against age-related decline (unproven)
• Cognitive benefits indirect (via better sleep)
• NOT a cognitive enhancer for healthy individuals

Verdict: FALSE

What IS Supported by Evidence

Strong evidence:

• Sleep onset improvement (modest)
• Jet lag prevention and recovery
• DSPS treatment
• Shift work sleep facilitation

Moderate evidence:

• Circadian rhythm optimization
• Migraine prevention
• Modest blood pressure reduction

Weak but possible:

• Long-term neuroprotection
• Antioxidant benefits at high doses
• Immune modulation in specific contexts

---

11. Melatonin Benefits Questions Answered

Does melatonin help with weight loss?

No direct weight loss effect. However, improved sleep quality (which melatonin may support) is associated with better metabolic health, reduced hunger hormones (ghrelin), and increased satiety hormones (leptin). Any weight benefit is indirect through sleep improvement, not melatonin itself. Melatonin is NOT a weight loss supplement.

Can melatonin improve athletic performance?

Limited evidence. Some studies show reduced oxidative stress and inflammation post-exercise at high doses (20mg+). Sleep quality improvement might indirectly benefit recovery. But no evidence for direct performance enhancement. Not worth taking specifically for athletic performance—focus on proven strategies (nutrition, training, sleep hygiene).

Will melatonin help my chronic pain?

Minimal evidence. Some migraine prevention benefit (see Section 7). General chronic pain: insufficient evidence. Pain improvement likely indirect (better sleep reduces pain perception). If pain disrupts sleep, melatonin might help sleep, which helps pain tolerance—but it's not an analgesic.

Does melatonin prevent dementia?

Unknown. Observational data suggests possible reduced risk with long-term use. Animal studies show neuroprotective effects. BUT no randomized controlled trials proving dementia prevention. Current evidence: hypothesis-generating, not conclusive. Maintain realistic expectations.

Is melatonin anti-inflammatory?

Yes, melatonin has anti-inflammatory properties in laboratory settings. Reduces inflammatory cytokines, modulates immune response. Human evidence: mixed. Some studies show reduced inflammation markers (CRP), others show no effect. At typical sleep doses (0.3-5mg), anti-inflammatory benefits probably minimal. Higher doses (10-20mg+) may have more pronounced effects but limited human data.

Can melatonin help with seasonal depression (SAD)?

Limited evidence. Circadian disruption contributes to SAD. Melatonin (combined with morning bright light) may help regulate disrupted winter rhythms. Some small studies show benefit. BUT bright light therapy alone has stronger evidence. Melatonin is NOT first-line SAD treatment—consider it complementary to light therapy, not standalone.

Does melatonin improve gut health?

Interesting area but preliminary. Gut produces melatonin locally. Some evidence for: reduced GERD symptoms, possible IBS benefit, protection against gut inflammation. But studies small and inconsistent. More research needed. NOT established gut health treatment.

Is melatonin beneficial for children with ADHD?

Complex. Children with ADHD often have delayed sleep phase (circadian issue). Melatonin can help sleep onset in this context (advance phase). Some studies show 20-30 minute improvement. BUT should only be used under medical supervision in children. Address behavioral sleep issues first. NOT for improving ADHD symptoms directly—only sleep-related difficulties.

---

Key Takeaways

Melatonin's strongest evidence-based benefits are circadian-related—jet lag prevention (50-70% symptom reduction), DSPS treatment (1-2 hour phase advance), and shift work sleep facilitation. These show large, consistent effects.

Sleep improvement is modest but real—7-12 minutes faster sleep onset on average, with best results in older adults (12-20 minutes), circadian disorders, and jet lag. Not transformative for general insomnia.

Effectiveness varies dramatically by use case—high benefit for circadian disruption (jet lag, DSPS, shift work), low benefit for anxiety-driven insomnia or sleep maintenance issues.

Antioxidant effects are well-documented in labs but translating to meaningful human health benefits at typical doses (0.3-5mg) remains unclear. Higher doses (50-100mg+) may provide more antioxidant benefit but safety less established.

Immune modulation is real but clinical significance uncertain—melatonin affects immune cells and inflammation, but evidence for "immune boosting" in healthy people is weak.

Migraine prevention shows moderate promise—3mg nightly reduces frequency by 50% in some patients. Takes 8-12 weeks. Works better for prevention than acute treatment.

Cognitive protection is theoretical—animal studies promising for neuroprotection and Alzheimer's prevention, but human evidence lacking. NOT an acute cognitive enhancer.

Cardiovascular benefits are modest—3-5 mmHg blood pressure reduction, possible improvements in vascular health markers. Not a replacement for standard cardiovascular treatments.

Many hyped benefits lack human evidence—cancer prevention, dramatic anti-aging, cognitive enhancement, weight loss, athletic performance all poorly supported despite marketing claims.

The dose-benefit relationship is not linear^[5]—more melatonin doesn't mean more benefits. Many effects plateau at 1-3mg. Higher doses increase side effect risk without proportional benefit increase.

---

Your Evidence-Based Melatonin Decision Plan

Step 1: Match Benefits to Your Goals (Now)

• [ ] Identify which benefits you're seeking
• [ ] Check evidence strength for those specific benefits
• [ ] Set realistic expectations based on research
• [ ] Determine if melatonin is appropriate for your goal
• [ ] Consider alternatives with stronger evidence if needed

Step 2: Optimize Dose for Your Use Case (Week 1)

• [ ] Circadian issues (jet lag, DSPS, shift work): 0.5-5mg
• [ ] Sleep onset in older adults (65+): 0.3-1mg
• [ ] Migraine prevention: 3mg
• [ ] General sleep improvement: 0.5-1mg
• [ ] Start low, increase only if needed

Step 3: Implement Correctly (Weeks 1-4)

• [ ] Time appropriately for goal (2-3 hours before bed for sleep, earlier for phase advance)
• [ ] Pair with complementary strategies (light exposure, sleep hygiene)
• [ ] Track objective outcomes (sleep diary, migraine log)
• [ ] Allow 2-4 weeks to assess effectiveness
• [ ] Adjust based on response, not assumptions

Step 4: Evaluate Results Honestly (Week 4-8)

• [ ] Compare outcomes to realistic research-based expectations
• [ ] The dose-benefit relationship is not linear^[5]
• [ ] If clear benefit, determine if long-term use appropriate
• [ ] Periodic breaks to reassess ongoing need
• [ ] Don't continue indefinitely without evaluating effectiveness^[6]

Step 5: Stay Informed (Ongoing)

• [ ] Monitor emerging research (field evolving)
• [ ] Distinguish marketing claims from evidence
• [ ] Recognize when benefits are indirect (via sleep) vs direct
• [ ] Annual review of whether continued use justified
• [ ] Consider alternatives if effectiveness wanes

Continue Learning:

• Complete Sleep Guide: Melatonin for Sleep Improvement
• Circadian Rhythm Science: How Melatonin Regulates Your Clock
• What Is Melatonin? Understanding the Hormone
• Dosage Guide: Finding Your Optimal Dose

Research References

1. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS ONE. 2013;8(5):e63773. PubMed
2. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS ONE. 2013;8(5):e63773. PubMed
3. Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727-4730. PubMed
4. Andersen LPH, Gögenur I, Rosenberg J, Reiter RJ. The safety of melatonin in humans. Clin Drug Investig. 2016;36(3):169-175. PubMed
5. DeMuro RL, Nafziger AN, Blask DE, Menhinick AM, Bertino JS. The absolute bioavailability of oral melatonin. J Clin Pharmacol. 2000;40(7):781-784. PubMed
6. Erland LA, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275-281. PubMed

---

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Melatonin research continues to evolve, and individual responses vary significantly. This review reflects current scientific understanding but is not comprehensive medical guidance. Always consult with a qualified healthcare provider before starting any supplement, especially if you have medical conditions, take medications, are pregnant or breastfeeding, or are considering melatonin for a child. Understanding research helps inform decisions, but professional medical advice is essential for your specific situation.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.